News

Filter

1 to 9 of 96198 results

OxThera’s Oxabact gains orphan drug designation in EU

OxThera’s Oxabact gains orphan drug designation in EU

23-09-2014

Privately-held Swedish biopharmaceutical company OxThera AB’s product Oxabact (oxalobacter formigenes)…

EUGastro-intestinalsOxabactOxTheraPharmaceuticalRegulationSweden

MMIP formally established to boost medicines manufacturing in the UK

23-09-2014

A new Medicines Manufacturing Industry Partnership (MMIP) has been jointly established by the Association…

ActavisEisaiFujifilm Diosynth BiotechnologiesGlaxoSmithKlineOxford BioMedicaPfizerPharmaceuticalProductionUK

Avillion appoints Jarrod Longcor as chief business officer

Avillion appoints Jarrod Longcor as chief business officer

23-09-2014

UK-based Avillion LLP, a co-developer of late-stage pharmaceutical assets, has named Jarrod Longcor as…

Avillion LLPBoardroomBosulifPharmaceuticalUK

Russian government mulling restrictions of foreigners in state drug tenders

Russian government mulling restrictions of foreigners in state drug tenders

23-09-2014

The Russian government may take a decision about the imposition of restrictions on the participation…

AsiaMarkets & MarketingPharmaceuticalPoliticsRussia

US Treasury to crack down on tax inversion M&A deals

US Treasury to crack down on tax inversion M&A deals

23-09-2014

The USA’s Department of the Treasury announced on Monday that it is taking action to reduce the tax…

FinancialMergers & AcquisitionsPharmaceuticalPoliticsUSA

IMS Health identifies 10 events that may transform the delivery of health care

IMS Health identifies 10 events that may transform the delivery of health care

23-09-2014

As the global market for drugs surpasses $1 trillion this year, growing payer scrutiny of value for money…

Anti-viralsFinancialGlobalHealthcarePharmaceuticalRegulationResearchVaccines

Amgen files BLA for BiTE immunotherapy blinatumomab

Amgen files BLA for BiTE immunotherapy blinatumomab

22-09-2014

USA-based Amgen has submitted a Biologics License Application (BLA) to the US Food and Drug Administration…

AmgenBiotechnologyblinatumomabOncologyRegulationUSA

Auxilium Pharma rejects Endo acquisition in favor of QLT deal

Auxilium Pharma rejects Endo acquisition in favor of QLT deal

22-09-2014

Auxilium Pharmaceuticals’ board of directors, after review of the unsolicited $2.2 billion takeover…

AuxiliumCanadaEndo InternationalMen's HealthMergers & AcquisitionsPharmaceuticalQLTUSA

1 to 9 of 96198 results

Back to top